biologic

Change of Ownership for US CDMO Alcami

UK specialist healthcare investor GHO Capital Partners and US investment firm The Vistria Group have entered into an agreement to buy a controlling interest in US CDMO Alcami from current private equity owners Madison Dearborn Partners (MDP) and Ampersand Capital Partners. Financial terms of the deal were not disclosed.

The Need for Innovation in Pharmaceutical Manufacturing

Sanofi Sues US Merck over Insulin Drug

Janssen Boosts Metabolism Portfolio with Hanmi Biologic